Stifel Nicolaus Downgrades AdaptHealth (NASDAQ:AHCO) to Hold

Stifel Nicolaus cut shares of AdaptHealth (NASDAQ:AHCO – Get Rating) from a buy rating to a hold rating in a report published on Tuesday morning, The Fly reports.

Several other analysts have also issued reports on the company. TheStreet lowered AdaptHealth from a c- rating to a d+ rating in a research note on Thursday, April 6th. Robert W. Baird dropped their price target on AdaptHealth from $31.00 to $23.00 and set an outperform rating on the stock in a research note on Wednesday, March 1st. Truist Financial decreased their price objective on shares of AdaptHealth from $20.00 to $17.00 and set a buy rating on the stock in a report on Thursday, April 13th. SVB Securities dropped their price objective on shares of AdaptHealth from $30.00 to $23.00 in a research report on Wednesday, March 1st. Finally, Bank of America downgraded shares of AdaptHealth from a buy rating to a neutral rating and reduced their target price for the stock from $21.00 to $12.00 in a report on Tuesday. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $23.00.

AdaptHealth Price Performance

NASDAQ:AHCO opened at $11.30 on Tuesday. The stock has a market capitalization of $1.52 billion, a PE ratio of 43.46, a P/E/G ratio of 0.64 and a beta of 0.66. AdaptHealth has a 1-year low of $10.21 and a 1-year high of $27.48. The firm has a fifty day simple moving average of $12.85 and a 200 day simple moving average of $18.21. The company has a current ratio of 1.28, a quick ratio of 1.00 and a debt-to-equity ratio of 1.00.

AdaptHealth (NASDAQ:AHCO – Get Rating) last announced its quarterly earnings data on Monday, February 27th. The company reported $0.01 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.30). The firm had revenue of $780.28 million during the quarter, compared to the consensus estimate of $787.96 million. AdaptHealth had a net margin of 2.33% and a return on equity of 3.34%. On average, research analysts expect that AdaptHealth will post 0.69 EPS for the current fiscal year.

Hedge Funds Weigh In On AdaptHealth

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AHCO. Mesirow Institutional Investment Management Inc. acquired a new stake in shares of AdaptHealth during the first quarter valued at about $25,000. Versant Capital Management Inc bought a new position in AdaptHealth in the 3rd quarter valued at approximately $26,000. Tower Research Capital LLC TRC boosted its position in AdaptHealth by 610.0% during the 1st quarter. Tower Research Capital LLC TRC now owns 3,394 shares of the company’s stock worth $42,000 after buying an additional 2,916 shares during the period. Group One Trading L.P. grew its holdings in AdaptHealth by 134.3% during the 1st quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock worth $60,000 after acquiring an additional 2,132 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its position in AdaptHealth by 49.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,675 shares of the company’s stock valued at $71,000 after acquiring an additional 1,209 shares during the period. 86.33% of the stock is owned by institutional investors and hedge funds.

AdaptHealth Company Profile

(Get Rating)

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.